Biotech Values

[DewDiligence]

SNY Reports 4Q09 Annualized Lovenox Sales of $4.2B, $2.4B in US

[Sanofi’s reporting currency is the Euro, but the growth rates shown
below are in local currencies. Tallying growth in local currencies is a
way to track the change in volume and price irrespective of exchange
rates. The figures below are annualized, i.e. they are 4x the reported
4Q09 numbers.]


Worldwide Lovenox sales rose 8% year-over-year to an annualized rate of €3.02B, which is $4.2B at the current exchange rate.

US Lovenox sales rose 9% year-over-year to an annualized rate of €1.77B, which is $2.4B at the current exchange rate.

The breakdown of annualized 4Q09 Lovenox sales by geography is as follows; growth rates are year-over-year in local currencies:

US: €1.77B (59% of total), 9% growth
EU: €908M (30% of total), 7% growth
RoW: €336M (11% of total), 6% growth
===
Total: €3.02B, 8% growth

Source: http://en.sanofi-aventis.com/binaries/20100210_Results2009_en_tcm28-27173.pdf